VVOS 8-K 2026-10-19

Vivos Therapeutics, Inc. (VVOS) 8-K dated 2026-10-19 — accession 0001493152-26-047601. This URL is the filing, not the VVOS hub.

Vivos Therapeutics, Inc. (VVOS) is a medical devices company listed on NASDAQ.

Vivos Therapeutics, Inc. filed a 8-K on 2026-10-19. Accession 0001493152-26-047601.

Cached items: 1.01, 2.01, 3.02, 3.03, 5.03, 7.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M.

Not investment advice. The VVOS SEC hub lists recent forms. The stock page is the research view.